Papaverine HCl 150 mg Oral Capsule
RxNorm 312215
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 312215 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: papaverine HCl 150 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Papaverine 150 mg Oral Capsule
(Atom ID: 12339787)
PSN
Prescribable Name (PSN):
Papaverine HCl 150 mg Oral Capsule
(Atom ID: 6366170)
PT
Designated preferred name (PT):
Papaverine hydrochloride 150 mg oral capsule
(Atom ID: 10302806)
FN
Full form of descriptor (FN):
Product containing precisely papaverine hydrochloride 150 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10315863)
Patient Education
Papaverine
Papaverine is used to improve blood flow in patients with circulation problems. It works by relaxing the blood vessels so that blood can flow more easily to the heart and through the body. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.